Special Ep: A Conversation w the President of Moderna, Dr. Stephen Hoge On Building Back Trust Post-Covid

Today, we’re joined by Dr. Stephen Hoge, president of Moderna, the biotech company that helped make mRNA a household name during the pandemic, producing a vaccine taken by millions of Americans.

Now, Moderna is using that same technology to push into new frontiers, developing treatments for cancers like melanoma and lung cancer. While at the same time, mistrust of mRNA and of the pharmaceutical industry more broadly has only grown.

We discuss with Dr. Hoge his company's latest innovations in cancer treatment as well as an mRNA-based flu vaccine they are hoping to have available before the next flu season. We discuss what it's like to try and innovate using a platform that many Americans, coming off the pandemic experience, do not trust. And we talk about whether using mRNA as a tool against cancer might yield a different reception.  

Hosts:

Brinda Adhikari

Tom Johnson

Maggie Bartlett

Dr. Mark Abdelmalek

Guest:

Dr. Stephen Hoge, President of Moderna

Thanks for listening! If you like us, please leave a review, rate us, and please subscribe! 

Got questions? Comments? We'd love to hear from you! Email us at [email protected]